Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy

This publication has 47 references indexed in Scilit:

• Characterization of human blood dendritic cell subsets
  Blood, 2002
• Competent dendritic cells derived from CD34⁺ progenitors express CMRF‐44 antigen early in the differentiation pathway
  Immunology & Cell Biology, 2002
• Immunologic Profiles of Effector Cells and Peripheral Blood Stem Cells Mobilized with Different Hematopoietic Growth Factors
  The International Journal of Cell Cloning, 2000
• Dendritic Cells in Cancer Immunotherapy
  Annual Review of Immunology, 2000
• Dendritic cell immunotherapy for cancer: Application to low‐grade lymphoma and multiple myeloma
  Immunology & Cell Biology, 1999
• Vaccination of melanoma patients with peptide-pulsed dendritic cells
  Melanoma Research, 1997
• Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1995
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
  Nature, 1992